Anders Forss
Overview
Explore the profile of Anders Forss including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
93
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Forss A, Broms G, Bergman D, Thuresson M, Sun J, Eriksson C, et al.
Am J Gastroenterol
. 2025 Mar;
PMID: 40079472
Introduction: Inflammatory diseases have been associated with increased risk of venous thromboembolism (VTE). However, data on VTE is lacking in large population-based cohorts of microscopic colitis (MC). Methods: This study...
2.
Hjalte V, Myrelid P, Hjortswang H, Rejler M, Ludvigsson J, Forss A, et al.
Aliment Pharmacol Ther
. 2025 Mar;
PMID: 40065562
Background: The corticosteroid-sparing effects of ileocaecal resection have not been thoroughly investigated in a population-based cohort. Aim: To investigate systemic corticosteroid use before and after primary ileocaecal resection in patients...
3.
4.
Ebrahimi F, Ebrahimi R, Hagstrom H, Sundstrom J, Sun J, Bergman D, et al.
Circ Cardiovasc Qual Outcomes
. 2024 Nov;
17(11):e010912.
PMID: 39503614
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a risk factor for cardiovascular disease. However, whether family members of individuals with MASLD also share an increased cardiovascular risk is unknown....
5.
Ebrahimi F, Forss A
Aliment Pharmacol Ther
. 2024 Oct;
60(10):1449-1450.
PMID: 39415713
No abstract available.
6.
Marild K, Soderling J, Axelrad J, Halfvarson J, Forss A, Michaelsson K, et al.
Aliment Pharmacol Ther
. 2024 Sep;
60(11-12):1549-1560.
PMID: 39308339
Background: Individuals with inflammatory bowel disease (IBD) are at increased risk of fracture. It is unclear if this risk varies by recent histological activity. Aims: To determine the fracture risk...
7.
Bergman D, Forss A, Sun J, Ebrahimi F, Ludvigsson J
Gut
. 2024 Aug;
74(3):506-508.
PMID: 39214672
No abstract available.
8.
Forss A, Ma W, Thuresson M, Sun J, Ebrahimi F, Bergman D, et al.
Eur Heart J Qual Care Clin Outcomes
. 2024 Aug;
PMID: 39174483
Background: An increased risk of cardiovascular disease (CVD) has been reported in patients with diverticular disease (DD). However, there are knowledge gaps about specific risks of each major adverse cardiovascular...
9.
Forss A, Uchida A, Roelstraete B, Ebrahimi F, Garber J, Sundstrom J, et al.
Esophagus
. 2024 May;
21(3):365-373.
PMID: 38809488
Background: Inflammatory diseases have been associated with an increased cardiovascular risk. However, data on incident major adverse cardiovascular events (MACE) from large population-based cohorts of patients with eosinophilic esophagitis (EoE)...
10.
Yang Y, Ludvigsson J, Forss A, Faucon A, Faye A, Olen O, et al.
Clin Gastroenterol Hepatol
. 2024 May;
22(11):2291-2298.e17.
PMID: 38777172
Background & Aims: Inflammatory bowel disease (IBD) is frequently accompanied by kidney complications. Potential triggers or subpopulations at high-risk of kidney problems are not well-elucidated. We hypothesized that surgical interventions,...